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Background: The purpose of this study was to analyze the outcomes of ceramic bearings used in primary
total hip arthroplasty (THA) in the Medicare population.
Methods: A total of 315,784 elderly Medicare patients (65þ) who underwent primary THA between 2005
and 2014 were identiﬁed from the United States Medicare 100% national administrative hospital claims
database. Outcomes of interest included infection, dislocation, revision, or mortality at any time point
after primary surgery. Propensity scores were developed to adjust for selection bias in the choice of
bearing type at index primary surgery.
Results: For primary THA patients treated with ceramic-on-polyethylene (C-PE) bearings and
ceramic-on-ceramic (COC) bearings, there was signiﬁcantly reduced risk of infection relative to
metal-on-polyethylene (M-PE) bearings (C-PE hazard ratio [HR]: 0.86, P ¼ .001; COC HR: 0.74, P ¼ .01).
For the C-PE cohort, we also observed reduced risk of dislocation (HR: 0.81, P < .001) and mortality
(HR: 0.92, P < .001). There was no signiﬁcant difference in risk of revision for either the C-PE or COC
bearing cohorts when compared with M-PE. For the COC cohort, there was no signiﬁcant difference in
dislocation or mortality risk.
Conclusion: As in previous studies, we found that ceramic bearings have similar overall revision risk as
M-PE bearings in primary THA at 8-9 years of follow-up. The results indicate that, after adjusting for
selection bias and various confounding patient-, surgeon-, and hospital-related factors, Medicare primary
THA patients treated with ceramic bearings exhibit lower risk of infection than those treated with M-PE
bearings. In addition, C-PE bearings were associated with lower risk of dislocation and mortality.
© 2016 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).Ceramic bearings, including ceramic-on-ceramic (COC) and
ceramic-on-polyethylene (C-PE), are currently the most widely
used alternative to metal-on-polyethylene (M-PE) bearings in totalnducted in conformity with
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Inc. This is an open access article uhip arthroplasty (THA) [1]. The long-term successful clinical
survivorship of contemporary ceramic bearings is now well
established [1,2]. Ceramic bearings were initially developed
because of their improved wear resistance relative to M-PE [3,4].
More recently, the use of ceramic femoral heads have been shown
to reduce the risk of metal release due tomodular taper fretting and
corrosion [5]. On the other hand, ceramic bearings have known
disadvantages, including their increased cost [6]; low fracture risk
[2,7-9]; and, with COC hips, squeaking [10].
It has been suggested that COC bearings may be associated with
reduced dislocation risk [11,12] and reduced infection risk [13].
Interest in ceramic bearings as a potential mitigating factor for
dislocation was ﬁrst raised by researchers from France who, at
long-term follow-up, observed fewer late dislocations, less tissue
damage, and better preserved hip musculature around the hips of
patients implanted with COC in the 1970s and 1980s as opposed to
C-PE [11,14]. There can be little doubt that 32-mm diameter headsnder the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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up to the 1980s, would be susceptible to much greater volumetric
wear than COC hips and concomitant periprosthetic inﬂammation.
It is also known, however, that modern highly crosslinked poly-
ethylenes have greatly reduced the wear and risk of osteolysis in
today's hip arthroplasties [15] so it is unclear how to apply the
ﬁndings of Hernigou et al [11,14] to modern implants and surgical
techniques. Thus, whether ceramic bearings reduce long-term
dislocation risk is an open topic in the literature and is compli-
cated by differences in head size, surgical approach, and poly-
ethylene bearing materials over the years.
Recently Pitto and Sedel [13] introduced the concept that COC
bearings may reduce infection risk. They analyzed clinical outcome
data from the New Zealand Registry over a 15-year period and
compared the risk of revision due to deep infection among ceramic
bearings and metal bearings. Although they found a reduced risk of
infection among patients treated with COC bearings, the only
patient factors they accounted for in their Cox regression analysis
were age and gender. However, the researchers did not account for
patient health status (ie, comorbidities) or obesity, which are
among the most important predictors of infection risk in THA [16].
The previous study also did not address surgeon bias in bearing
selection with their analysis [17]. For these reasons, further
exploration of the hypothesized association between ceramic
bearing usage and risk of deep infection was warranted.
Our group recently studied the outcomes of ceramic bearings
after revision surgery among Medicare beneﬁciaries [18]. We pre-
viously accounted for differences in patient health status by
including comorbidities as potential confounders, and we
employed propensity scores to account for potential surgeon bias in
selection of bearing surfaces [17]. For revision THA patients treated
with C-PE bearings, we observed a reduced risk of 90-day read-
mission (hazard ratio, HR: 0.90, P¼ .007) as well as a suggestion for
reduced risk of infection with C-PE (HR: 0.88, P ¼ .14). Among
revision THA patients who received COC bearings, we observed a
reduced risk of dislocation (HR: 0.76, P ¼ .04). As our analysis used
propensity scores [17] to account for the potential of confounding
due to differences in patient and clinical factors between cohorts,
our previous research [18] supported the hypothesis that ceramic
bearings may inﬂuence patient outcomes besides survivorship.
The previous ﬁndings from revision THA [18] prompted us to
examine the outcomes of ceramic bearings for primary THA,
including revision, dislocation, infection, and mortality. Accord-
ingly, we tested the hypothesis that ceramic bearings improve
clinical outcomes of primary THA when compared with traditional
M-PE bearings. We sought to answer the following research ques-
tions in the Medicare population: (1) does the use of C-PE bearings
inﬂuence outcomes following THA as compared with M-PE; and (2)
does the use of COC bearings inﬂuence outcomes following THA as
compared with M-PE?
Methods
We used the Medicare 100% fee-for-service claims database for
hospital stays to identify primary THA patients between October 1,
2005, and December 31, 2014. We applied the same exclusion
criteria as in our previous study [18]: speciﬁcally we excluded
patients <65 years old; those enrolled in a health maintenance
organization; and those living outside of the 50 states. A 1-year pre-
THA enrollment is also required. This 1-year period was used to
compile health status and comorbidities prior to patients pre-
senting themselves for THA. Thus, our present study is composed of
elderly Medicare beneﬁciaries for primary hip arthroplasty.
Unique, encrypted Medicare beneﬁciary identiﬁers were used to
follow patients longitudinally throughout the study period.Patient's Medicare entitlement status and mortality were tracked
using a linked “denominator” ﬁle provided by the Centers for
Medicare and Medicaid Services that accompanied the analytic
data sets. The International Classiﬁcation of Diseases, Ninth Revi-
sion, Clinical Modiﬁcation (ICD-9-CM: 81.53) procedure code was
used to identify primary THA patients. Our focus was to investigate
outcomes as a function of bearing surface used in the primary THA,
which was identiﬁed in the primary THA claim record using an ICD-
9-CM code of 00.74 (M-PE), 00.76 (COC), and 00.77 (C-PE). These
bearing surface codes were introduced in October 2005 for M-PE,
metal-on-metal, and COC bearings. In October 2006, the code for C-
PE was introduced. As a result, the C-PE cohort has 1 less year of
follow-up than the other bearing surface cohorts in this study.
The 4 outcomes of interest included periprosthetic joint infection,
dislocation, revision, or death at any time point following the index
primary THA procedure during the study period. Periprosthetic joint
infectionwas identiﬁed using an ICD-9-CM diagnosis code of 996.66
[19], whereas dislocation was identiﬁed using ICD-9-CM diagnosis
codes of 718.35, 835.00-835.03, and 996.42 (effective October
2005) [20]. Revision was identiﬁed using ICD-9-CM revision codes
(ICD-9-CM: 81.53, 00.70-00.73), and death was identiﬁed using the
previously mentioned denominator ﬁle accompanying the inpatient
analytical data set. We used the Kaplan-Meier approach to inspect
the crude (unadjusted) survivorship of the M-PE, C-PE, and COC
cohorts for each of the outcomes of interest.
Propensity scores were developed to adjust for selection bias in
the choice of bearing type for primary THA surgery [18]. As dis-
cussed in a recent review [17], propensity scores were used to treat
large data sets of retrospective registry data, such as the Medicare
claims administrative data, for selection bias. We employed the
same approach with the application of propensity scores an in our
previous study [18]. Speciﬁcally, the propensity score calculates a
patient's chance of receiving a C-PE or COC implant, given certain
patient and hospital factors. The propensity score was calculated
for each patient using the following predictors: age; sex; region;
race; Medicare buy-in (a proxy for socioeconomic status); Charlson
comorbidity score; revision calendar year; length of stay; hospital
charge amount; hospital and surgeon joint arthroplasty volume;
hospital location (urban/rural); hospital type (eg, public, private);
size of hospital; diabetes; heart disease; obesity; and 2-way in-
teractions among age, gender, race, Charlson score, hospital size,
and hospital type. Separate scores were calculated for patients
receiving C-PE and COC implants.
Cox regression incorporating propensity score stratiﬁcation
(10 levels) was then used to evaluate the impact of bearing surface
selection on outcomes, after adjusting for patient-, hospital-, and
surgeon-related factors [18]. The Cox model was stratiﬁed into 10
propensity strata, and the overall HRswere estimated as the relative
risk of infection, dislocation, and other outcomes between the
ceramic and conventional bearing. Because the Medicare data
afford the study with a large cohort of THA patients, a 10-level
stratiﬁcation provides reasonably well-matched propensity levels
between ceramic and conventional bearing patients. The Cox
regression model incorporated the main study variables: bearing
type (C-PE, COC, or M-PE) as well as the following potential
confounding variables: patient age; race; resident Census region;
patient diagnosis of diabetes, heart disease, or obesity; patient
Charlson comorbidity index; hospital type, location, and size; hos-
pital procedure volume; surgeon procedure volume; total hospital
charges; length of stay; Medicare buy-in; operating room charges;
and calendar year. Death and revision can be considered competing
events for other outcomes such as infection and dislocation.
Although the cumulative incidence function approach has been
suggested as an alternative to the conventional Cox regression, it is
not universally embraced. For this study, the competing risk is
Table 1
Overall Patient Demographics.
Effect Level Metal-on-Polyethylene Ceramic-on-Polyethylene Ceramic-on-Ceramic Total % Metal-on-Polyethylene % Ceramic-on-Polyethylene % Ceramic-on-Ceramic % Total
Total 235,800 70,496 9498 315,794 100.0 100.0 100.0 100.0
Age 65-69 57,092 28,394 3628 89,114 24.2 40.3 38.2 28.2
70-74 62,594 19,460 2402 84,456 26.5 27.6 25.3 26.7
75-79 56,148 12,258 1749 70,155 23.8 17.4 18.4 22.2
80-84 39,480 7046 1113 47,639 16.7 10.0 11.7 15.1
85þ 20,486 3338 606 24,430 8.7 4.7 6.4 7.7
Charlson Index (CCI) 00 132,681 41,973 5659 180,313 56.3 59.5 59.6 57.1
1-2 82,442 23,442 3153 109,037 35.0 33.3 33.2 34.5
3-4 16,263 4127 508 20,898 6.9 5.9 5.3 6.6
5þ 4414 954 178 5546 1.9 1.4 1.9 1.8
Discharge type Home 40,712 16,368 1592 58,672 17.3 23.2 16.8 18.6
Home with
home health
services
76,197 27,889 3306 107,392 32.3 39.6 34.8 34.0
Other facility 3227 699 170 4096 1.4 1.0 1.8 1.3
Rehab facility 28,548 6283 1455 36,286 12.1 8.9 15.3 11.5
Skilled
nursing facility
87,116 19,257 2975 109,348 36.9 27.3 31.3 34.6
Hospital annual
total joint
arthroplasty
volume
150-300 62,280 19,781 2683 84,744 26.4 28.1 28.2 26.8
300-450 45,986 12,834 1555 60,375 19.5 18.2 16.4 19.1
450-600 31,738 8596 1486 41,820 13.5 12.2 15.6 13.2
600þ 61,690 17,868 1866 81,424 26.2 25.3 19.6 25.8
<150 34,106 11,417 1908 47,431 14.5 16.2 20.1 15.0
Hospital beds 001-149 45,691 16,552 2000 64,243 19.4 23.5 21.1 20.3
150-299 62,845 18,330 2380 83,555 26.7 26.0 25.1 26.5
300-499 65,304 16,025 2563 83,892 27.7 22.7 27.0 26.6
500þ 61,960 19,589 2555 84,104 26.3 27.8 26.9 26.6
Hospital ownership Nonproﬁt 30,555 9784 1694 42,033 13.0 13.9 17.8 13.3
Private 183,405 54,488 7088 244,981 77.8 77.3 74.6 77.6
Public 21,840 6224 716 28,780 9.3 8.8 7.5 9.1
Hospital setting Rural 25,629 5985 716 32,330 10.9 8.5 7.5 10.2
Urban 210,171 64,511 8782 283,464 89.1 91.5 92.5 89.8
Hospital stay 1-2 45,004 22,109 1545 68,658 19.1 31.4 16.3 21.7
3-4 159,405 42,407 6376 208,188 67.6 60.2 67.1 65.9
5þ 31,391 5980 1577 38,948 13.3 8.5 16.6 12.3
Hospital teaching No 153,154 47,903 6684 207,741 65.0 68.0 70.4 65.8
Yes 82,646 22,593 2814 108,053 35.0 32.0 29.6 34.2
Race Black 8469 2872 408 11,749 3.6 4.1 4.3 3.7
Other/unknown 4362 1571 292 6225 1.8 2.2 3.1 2.0
White 222,969 66,053 8798 297,820 94.6 93.7 92.6 94.3
Resident region Midwest 66,829 14,441 1960 83,230 28.3 20.5 20.6 26.4
North East 55,633 14,254 2016 71,903 23.6 20.2 21.2 22.8
South 61,130 23,940 3427 88,497 25.9 34.0 36.1 28.0
West 52,208 17,861 2095 72,164 22.1 25.3 22.1 22.9
Sex Female 148,387 42,318 5673 196,378 62.9 60.0 59.7 62.2
Male 87,413 28,178 3825 119,416 37.1 40.0 40.3 37.8
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Table 2
Summary of Hazard Ratios, COC, and C-PE, Compared With M-PE.
Postoperative
Complication
COC vs M-PE C-PE vs M-PE
HR 95% CI, P Value HR 95% CI, P Value
Mortality 0.97 0.92-1.02, .235 0.92 0.88-0.95, <.001
Dislocation 0.97 0.83-1.13, .701 0.81 0.74-0.88, <.001
Infection 0.74 0.59-0.93, .010 0.86 0.78-0.94, .001
Revision 1.10 0.85-1.42, .461 0.95 0.89-1.01, .095
COC, ceramic-on-ceramic; C-PE, ceramic-on-polyethylene; M-PE, metal-on-
polyethylene; HR, hazard ratio; CI, conﬁdence interval.
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outcome separately. Records with nonobservance of the speciﬁc
outcome due to death, revision, or other reasons (eg, end-of-study,
termination of Medicare enrollment) are censored. About 13% died
during the follow-up period and about 4% of the primary THA
patients had a revision detected, and some of these revisions
undoubtedly are associated with infection. Cumulative incidence
function approach in data with modest level of competing risk
censoring generally leads to results comparable to those using
cause-speciﬁc hazard modeling. All statistical analyses were per-
formed using SAS statistical software (version 9.4, Cary, NC).Results
A total of 315,784 elderly Medicare patients who underwent
primary THA between 2005 and 2014 with known bearing types
were identiﬁed from the Medicare 100% hospital administrative
database, including 70,495 patients who received C-PE, 9497Fig. 1. Relative importance of patient, clinical, and institution factors on risk of mortality, dislo
PE bearings. The effect size for each factor is judged by the relative magnitude of the model W
LOS, length of stay; OR, operating room.patients who received COC, and 235,792 patients who received
M-PE bearings (Table 1). The THA patients in this study were 62%
female, on average (±standard deviation) 74.3 ± 6.5 years old, 94%
white, and 57% had no signiﬁcant comorbidities (corresponding to
a Charlson score of 0, Table 1). The usage of C-PE implants in THA
was highest in the 65-69 years age category (32% of THAs in that
cohort) and lowest among those ages 85þ (14% of THAs in that
cohort). The percentage of patients receiving COC implants, on the
other hand, was more uniform among all age cohorts and varied
between 2% and 4% of THAs in each age category.
Utilization of C-PE and COC was the same between male (40%)
and female (60%) patients, which is similar to the male and female
ratio of 37% vs 63% for M-PE. Although patients with bearing codes
were dominantly white in this study, the utilization of ceramic
bearings was homogeneous across races. For instance, 22% of white
patients, 24% of black patients, and 25% of patients of unknown/
other races received C-PE whereas the utilization of COC bearings
were 3%, 3%, and 5% for white, black, and unknown/other races,
respectively. While patients in the midwest received the largest
number of M-PE implants (66,829), patients in the south received
the largest number of C-PE (23,940) and COC (3427) implants.
Among patients with M-PE implants, 14.4% died during the study
period, compared with 6.1% mortality among the C-PE and 15.8%
among the COC patients. As an outcome, mortality is more common
than dislocation (1.5%), infection (1.1%), or revision (4.0%).
For THA patients treatedwith C-PE bearings, therewere reduced
risks of dislocation (HR: 0.81, 95% conﬁdence interval [CI]:
0.74-0.88, P < .001), infection (HR: 0.86, 95% CI: 0.78-0.94, P¼ .001)
and mortality (HR: 0.92, 95% CI: 0.88-0.95, P < .001) compared to
M-PE bearings (Table 2). We also observed a suggested trend forcation, infection, and revision following primary total hip arthroplasty using C-PE vs M-
ald chi-squared statistic. C-PE, ceramic-on-polyethylene; M-PE, metal-on-polyethylene;
Fig. 2. Relative importance of patient, clinical, and institution factors on risk of mortality, dislocation, infection, and revision following primary total hip arthroplasty using COC vs
M-PE bearings. The effect size of each factor is judged by the relative magnitude of the model Wald chi-squared statistic. COC, ceramic-on-ceramic.
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did not reach statistical signiﬁcance (P ¼ .10). Based on the multi-
variate Cox model, the adjusted survivorship at 8 years, using
infection as an end point (with 95% conﬁdence intervals), was 98.3%
(98.2%-98.4%) for M-PE, 98.5% (98.4%-98.7%) for C-PE, respectively.
The Charlson comorbidity index consistently ranked among the
most important predictors for death, dislocation, and revision and
was the second most important predictor for infection (Fig. 1).
Obesity was the most important risk factor for infection. Obesity
was also the second most inﬂuential factor for revision.
For THA patients treated with COC, there was reduced risk of
infection (HR: 0.74, 95% CI: 0.59-0.93, P ¼ .01) (Table 2). After
propensity score stratiﬁcation and adjustment for confounders,
there was no signiﬁcant difference in risk of dislocation (P ¼ .70),
revision (P ¼ .46), and mortality (P ¼ .24) for the COC bearing co-
horts when compared with M-PE. The adjusted survivorship at 8
years, using infection as an end point (with 95% conﬁdence in-
tervals), was 98.7.0% (98.5%-99.0%) for the COC cohort. When COC
and M-PE cohorts were compared, Charlson index was the most
important predictor for dislocation and revision (Fig. 2). For mor-
tality, age was the most important predictor followed by Charlson
score. Obesity was the most important predictor for infection.
Discussion
In this study of primary total hip surgery patients in the elderly
Medicare population, we asked how the use of ceramic bearings
inﬂuenced outcomes relative to M-PE. Overall, the ﬁndings for
the C-PE cohort relative to M-PE supported our hypothesis that
outcomes, speciﬁcally infection, dislocation, and mortality, were
associated with ceramic bearing selection. The ﬁndings for the COCcohort likewise showed an association between ceramic bearing
usage and reduced infection, but other outcomes were not signiﬁ-
cantly impacted.
In theory, the questions we posed in the present study could be
addressed by a long-term prospective randomized controlled trial;
however, due to the sample size considerations and the length of
the study, such an approach is neither economically nor practically
feasible. On the other hand, advanced statistical techniques, such as
the propensity score approach we adopted for the present study,
were developed speciﬁcally to address issues of selection bias that
may be introduced in the nonrandom assignment of therapies to
different arms of a clinical study [17]. In real-world clinical condi-
tions, physicians naturally tailor interventions based upon their
patients' characteristics and truly blinded random assignment of
treatment is not realistic. For example, younger (and healthier)
patients are more often selected for ceramic bearings than patients
receiving M-PE bearings. It is precisely this type of selection bias
that we sought to overcome by implementing the propensity score
approach for the present study. Nonetheless, certain nonobserved
cofounding factors may still be present, whose effect cannot be
controlled by the propensity stratiﬁcation or direct adjustment in
the Cox model. Additionally, our study was limited to THAs in the
Medicare records with known bearing codes. Over half of the THAs
in the Medicare records did not include the ICD-9-CM codes that
report the bearing material use. An informal review of the non-
reporting patients has not revealed distinct differences that may
have biased the study results; however, we cannot exclude the
possibility of nonreporting bias based on the inherent limitations of
the Medicare data set.
Our analysis was limited to the ICD-9-CM classiﬁcation of pro-
cedures and diagnoses codes that comprise administrative billing
S.M. Kurtz et al. / The Journal of Arthroplasty xxx (2016) 1e76data. We attempted to include and adjust for the procedure
complexity and difﬁculty due to patient and clinical factors by
considering the patient's Charlson comorbidity index and length of
stay as proxies. We relied on the ICD-9-CM bearing codes for both
types of ceramic bearings and the control (M-PE) bearings; however,
these codes are general and do not distinguish between different
polyethylene formulations, different types of ceramic biomaterials,
or head size that were used clinically during the study period. In the
2000s, different formulations of highly crosslinked polyethylene and
different types of ceramic bearing materials (eg, BIOLOX delta) were
clinically introduced [21,22]. Furthermore, changes in femoral head
size up to 40mmwere clinically introduced during this period forM-
PE and C-PE bearings to improve joint stability and reduce disloca-
tion risk [20]. Because COC bearings are regulated by the stringent
Premarket Approval process, for many years, the only head size
clinically available in the United States incorporating BIOLOX delta
was 28 mm or 32 mm, with 36-mm COC bearings only being
approved by the US Food and Drug Administration as recently as
2013. For these reasons, the granularity of the administrative bearing
codes limits our ability to answer questions about speciﬁc formu-
lations of bearing materials and head size, especially for COC bear-
ings which, prior to 2013, were only available in head sizes of 32mm
or less throughout the United States.
THA outcomes such as revision and dislocation may be associ-
ated with surgical approach [23,24]. We were unable to account for
potential differences in surgical approach using the Medicare
database because this clinical information is not captured as part of
the administrative billing records. As a result, this study is limited
by its inability to address potential confounding between bearing
selection and surgical approach.
Consistent with the ﬁndings of international registries [9,25],
we found the revision risk was similar between ceramic bearing
cohorts and M-PE cohort for the Medicare population. In our study,
the longest follow-up was 8 years for the C-PE cohort and 9 years
for the COC cohort. Longer term follow-up may be needed to detect
differences in revision rates for the ceramic bearing cohorts relative
to M-PE; however, for an elderly patient population such as
Medicare beneﬁciaries, it may also be necessary to formally
examine the competing risks of revision and mortality. In the
present study, patients who died prior to revision were considered
censored, and more detailed analysis of competitive risks was
beyond the scope of the present study. Because mortality increases
with follow-up, the risk of complications that present relatively
early in a patient's history, such as infection and dislocation, war-
rant additional scrutiny as these complication risks will potentially
impact a greater patient population.
Our ﬁndings pertaining to infection, like those of Pitto and Sedel
[13], support an association between ceramic bearing usage and
reduced risk of infection. In contrast with Pitto's study, which
showed an effect only for COC bearings, we found lower infection
risk was associated with both C-PE and COC bearing cohorts rela-
tive to M-PE. Data from recent national conferences would suggest
that ceramics may be more resistant to infection than CoCr surfaces
[26-29], which may help explain our ﬁndings in the present study.
Certainly, the association between reduced infection and the use of
ceramic bearings warrants further research.
Previous studies have reported that COC bearings have lower
risk of dislocation compared with M-PE in primary THA [11,12].
Hernigou and coworkers compared the risk of dislocation in C-PE
and COC bearings implanted from 1978 to 1985. However, the C-PE
in that study incorporated historical, gamma air-sterilized poly-
ethylene for the acetabular liner that would generate biologically
active wear particles and helps to explain the periprosthetic
soft-tissue damage as compared with COC in these historical co-
horts. In our study, during which HXLPE was commonly used in theUnited States, we observed an association between reduced dislo-
cation and C-PE bearing usage relative to M-PE but not with COC.
Because dislocation risk is a function of head size, which was
constrained in the COC cohort due to regulatory limitations in the
United States, our ﬁndings are limited in this regard, for the reasons
we already discussed. It remains unclear why the C-PE cohort fared
better against dislocations than the M-PE.
The association between reduced mortality and the C-PE
bearing cohort was unexpected and difﬁcult to compare with the
literature because relatively few studies examine the association
between bearing usage and mortality [30]. In the United Kingdom,
researchers studied whether metal-on-metal bearing usage was
associated with increased revisions and reduced mortality [30]. In
the present study, we found the C-PE group was associated with
lower risk of complications, including infection and dislocation,
whichmay help explain the lower mortality rate in the C-PE cohort.
In summary, we did not observe a lower risk of revision in
either ceramic bearing cohort relative toM-PE. Our results indicate
that, after adjusting for selection bias and various confounding
patient-, surgeon-, and hospital-related factors, Medicare THA
patients treated with ceramic bearings experienced reduced risk of
infection and those treated speciﬁcally with C-PE bearings had, in
addition to reduced infection risk, lower odds of dislocation and
mortality. The ﬁndings of this study support further research into
the association between ceramic bearings and complication
avoidance in primary THA.
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